Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |